← back to search

Pierre Tiberghien

Biomarqueurs d’urgence et de réanimation · FR
🔎 Find collaborators in Immunology · Management of Technology and Innovation →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Immunology · Management of Technology and Innovation
Research interest
Research interests include Blood donation and transfusion practices, Hematopoietic Stem Cell Transplantation, Blood transfusion and management, and Immune Cell Function and Interaction.
h-index
66
citations
15,249
works
520
NIH funding
primary concept
Medicine
email

Recent publications

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
EBioMedicine 2025cited by 18position: middledoi
The seven enigmas of SARS-CoV-2: From the past to the future
Journal of Human Immunity 2025cited by 3position: middledoi
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease
The Journal of Experimental Medicine 2024cited by 27position: middledoi
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals
Journal of Clinical Investigation 2024cited by 12position: middledoi
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
BMJ Medicine 2023cited by 20position: lastdoi
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
The Journal of Experimental Medicine 2022cited by 45position: middledoi
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
Journal of Clinical Immunology 2022cited by 12position: middledoi
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
EBioMedicine 2022cited by 8position: lastdoi
Use of Granulocyte Transfusions in Two National Cohorts and Association between Transfusion Dose and Patient Outcomes: The Best Collaborative Study
Blood 2021cited by 2position: middledoi
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
Blood 2020cited by 299position: middledoi
Potential human transmission of amyloid β pathology: surveillance and risks
The Lancet Neurology 2020cited by 69position: middledoi
Patient Blood Management
JAMA 2019cited by 615position: middledoi
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
New England Journal of Medicine 2016cited by 544position: middledoi
Properties of donated red blood cell components from patients with hereditary hemochromatosis
Transfusion 2016cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2016–2016) · 1 papers (2016–2016)Craig French · The University of Melbourne1 papers (2019–2019)Ruth H. Keogh · Office of the Director1 papers (2021–2021) · 1 papers (2019–2019)Cécile Aubron · In-Q-Tel1 papers (2019–2019)Elhadj Ibrahima Bah · University of Manitoba1 papers (2016–2016)Emmy De Buck · KU Leuven1 papers (2019–2019)Michael Murphy · Roswell Park Comprehensive Cancer Center1 papers (2019–2019)Johan van Griensven · Instituut voor Tropische Geneeskunde1 papers (2016–2016) · 1 papers (2016–2016)Hans Van Remoortel · KU Leuven1 papers (2019–2019) · 1 papers (2016–2016)Katerina Pavenski · Unity Health Toronto1 papers (2019–2019) · 1 papers (2016–2016)Peter G. Smith · Kenya Medical Research Institute1 papers (2016–2016)Tansy Edwards · London School of Hygiene & Tropical Medicine1 papers (2016–2016)Jerrold H. Levy · Duke University Hospital1 papers (2019–2019)Erica M. Wood · Monash Health1 papers (2019–2019)Peter Horby · University of Oxford1 papers (2016–2016)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Immunology · Management of Technology and Innovation →